Free Trial
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

Pharma-Bio Serv logo
$0.58
0.00 (0.00%)
(As of 10/31/2024 ET)

About Pharma-Bio Serv Stock (OTCMKTS:PBSV)

Key Stats

Today's Range
$0.58
$0.58
50-Day Range
$0.52
$0.65
52-Week Range
$0.52
$1.09
Volume
N/A
Average Volume
477 shs
Market Capitalization
$13.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Pharma-Bio Serv Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
6th Percentile Overall Score

PBSV MarketRank™: 

Pharma-Bio Serv scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pharma-Bio Serv is -19.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pharma-Bio Serv is -19.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Pharma-Bio Serv has a P/B Ratio of 0.83. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.00% of the outstanding shares of Pharma-Bio Serv have been sold short.
  • Short Interest Ratio / Days to Cover

    Pharma-Bio Serv has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pharma-Bio Serv has recently increased by 33.33%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Pharma-Bio Serv does not currently pay a dividend.

  • Dividend Growth

    Pharma-Bio Serv does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the outstanding shares of Pharma-Bio Serv have been sold short.
  • Short Interest Ratio / Days to Cover

    Pharma-Bio Serv has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pharma-Bio Serv has recently increased by 33.33%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Pharma-Bio Serv has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Pharma-Bio Serv this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Pharma-Bio Serv insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.20% of the stock of Pharma-Bio Serv is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Pharma-Bio Serv's insider trading history.
Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Stock News Headlines

The real reason Elon is fully endorsing Trump
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
PBSV Makes Progress on Improvements
Pharma-Bio Serv Inc PBSV
Pharma-Bio Serv Inc.
See More Headlines

PBSV Stock Analysis - Frequently Asked Questions

Pharma-Bio Serv's stock was trading at $1.05 on January 1st, 2024. Since then, PBSV stock has decreased by 44.8% and is now trading at $0.58.
View the best growth stocks for 2024 here
.

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) issued its quarterly earnings results on Monday, September, 16th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.03 by $0.04. The company earned $2.42 million during the quarter, compared to analyst estimates of $3.50 million. Pharma-Bio Serv had a negative trailing twelve-month return on equity of 5.81% and a negative net margin of 7.81%.

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), General Electric (GE), Exxon Mobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP).

Company Calendar

Last Earnings
9/16/2024
Today
10/31/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
Business Services
Current Symbol
OTCMKTS:PBSV
Employees
185
Year Founded
N/A

Profitability

Net Income
$1.31 million
Pretax Margin
-7.32%

Debt

Sales & Book Value

Annual Sales
$16.98 million
Cash Flow
$0.07 per share
Book Value
$0.70 per share

Miscellaneous

Free Float
20,162,000
Market Cap
$13.32 million
Optionable
Not Optionable
Beta
0.57

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (OTCMKTS:PBSV) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners